is a partner in Kirkland’s London IP litigation team. She focuses her practice on patent litigation, particularly in the life sciences and tech sectors. Katie is experienced in dealing with multi-jurisdictional cases requiring significant cross-border co-ordination across multiple forums at both first instance and on appeal. She has litigated patents across a broad spectrum of technological subject matters, including those relating to antibody and other protein biologics, biological product development and screening platforms, checkpoint inhibitor immunotherapies, diagnostics and next generation sequencing technologies, medical devices, wireless and mobile telecommunications, and consumer product technologies. Katie holds a degree in Natural Sciences (Chemistry and Biology).
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.